ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

New Center Plan Discussed By NAB, Directors Committees

May 4, 1990

R. Lee Clark, 87, M.D. Anderson Mastermind, dies

May 13, 1994

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill

July 6, 1979